FDA Adverse Event Malfunction Summary report: N

SPRINT QUATTRO SECURE S

MDR report key: 2053128 · Received April 13, 2011

Report

Report Number
2649622-2011-05785
Event Type
Malfunction
Date Received
April 13, 2011
Date of Event
January 31, 2011
Manufacturer
MEDTRONIC PUERTO RICO, INC.
Product Code
LWS
PMA / PMN Number
P920015/S039
Removal / Correction Number
Z0474-2011
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. ANALYSIS OF THE LEAD IS IN PROCESS; THE RESULTS WILL BE FORWARDED WHEN AVAILABLE. THE DEVICE IS PART OF THE ADVISORY FOR THIS MODEL.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. THE DEVICE IS PART OF THE ADVISORY FOR THIS MODEL. EVALUATION SUMMARY FOR (B)(4): NO ANOMALIES FOUND. FULL LEAD RETURNED AND ANALYZED. ADDITIONAL FINDINGS OF INNER TUBING KINKED/BUCKLED, BLOOD IN/ON HELIX MECHANISM AND DAMAGED AT IMPLANT. THE ANALYST COMMENTED THAT NO THICKNESS WAS FOUND IN THE MIDDLE OF THE LEAD BODY AND THAT THE INTRODUCER TEST WAS PERFORMED.

Description of Event or Problem · 1

IT WAS REPORTED THAT AT IMPLANT THERE WAS THICKNESS IN THE MIDDLE OF THE LEAD BODY THAT CREATED NOTICEABLE RESISTANCE DURING THE LEAD INSERTION VIA THE HAEMOSTATIC VALVE. THE LEAD WAS NOT IMPLANTED AND ANOTHER LEAD WAS USED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SPRINT QUATTRO SECURE S IMPLANTABLE TACHY LEAD LWS MEDTRONIC PUERTO RICO, INC. 6935 ASKU

Patients

Seq Age Sex Outcome Treatment
1 Other